Le Lézard
Classified in: Health, Covid-19 virus
Subjects: PDT, PSF

P23 Labs Announces P23 Respiratory ONE


SAVANNAH, Ga., Sept. 18, 2020 /PRNewswire/ -- P23 Labs announces its new P23 Respiratory ONE, a test to detect respiratory illnesses that share symptoms with COVID-19 when test results for COVID-19 are negative and the patient is still not healthy. This test can detect the common cold, five different Influenza strains, and five Coronavirus strains including COVID-19.

P23 Respiratory ONE takes a single COVID-19 sample submitted to P23 Labs, whether it was the non-invasive saliva sample or the nasal swab sample, and rules out other illnesses testing a single sample across multiple assays.

To complete this test, it must be ordered by a physician, however, telemedicine solutions can help patients obtain access to P23 Respiratory ONE. If anyone is presenting COVID-19 symptoms and working with their physician to obtain a COVID-19 order, they should also tell their physician that they would like to have a test that identifies what illness they do have if it is not COVID-19.

The P23 Respiratory ONE is available now, and test results are available 48 hours from lab receipt.  

For more information, please contact [email protected].

About P23 Labs: P23 Labs is a high-complexity molecular diagnostics laboratory that specializes in preventative diagnostic testing of infectious disease. P23 Labs offers a full suite of molecular diagnostic tests that also include COVID-19, respiratory pathogen profiles, and other infectious diseases rapidly identified via our state-of-the-art molecular methods. Our emphasis is on women's health and serving the underserved communities in the United States. P23 Labs is dedicated to removing healthcare barriers and improving healthcare literacy.

Founded in 2020, P23 Labs captured on the unique opportunity for a quality laboratory that focuses on fortifying the relationship between patients and providers by increasing access to healthcare. P23 Labs is headquartered in Little Rock, Arkansas, and has a premier testing facility in Savannah, Georgia. For more information, visit www.p23labs.com.

Related Images

image1.png

Related Links

P23 Labs

 

SOURCE P23 Labs


These press releases may also interest you

at 20:50
Pharma (1167.HK), a clinical-stage oncology company drugging the undruggable targets, today announced its 2023 annual results. The revenue was RMB63.5 million, the R&D investment was RMB372 million, the cash and cash equivalent at the end of 2023 was...

at 20:35
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company announced that the first patient in China has been dosed in the Phase 1b clinical study of the combination of InnoCare's novel SHP2 (Src Homology 2 domain containing...

at 19:30
Willow Biosciences Inc. ("Willow" or the "Company") , a leading biotechnology...

at 18:56
Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:...

at 18:30
Striking Teamsters at pharmaceutical giant Cencora (formerly known as AmerisourceBergen) rallied today outside the company's Sacramento distribution center. The 124 warehouse workers are members of Teamsters Local 150 and have been on strike since...

at 18:00
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Jessica M. Konen's Lab at Emory University School of Medicine....



News published on and distributed by: